Business of Bioanalysis: Creating Additional Value Through M&A

Watch Dr. Afshin Safavi, BioAgilytix Global CSO explain that when two companies come together their combined value should be more than a sum of their parts as part of the “Business of Bioanalysis” panel hosted by Bioanalysis Zone.

*Video Produced by Bioanalysis Zone

Share This